A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study

Arthritis research & therapy

Volumn 19, Issue 1, 2017, Pages 185-

  Nakagawa, Jin ^a   Koyama, Yoshinobu ^a   Kawakami, Atsushi ^a   Ueki, Yukitaka ^a   Tsukamoto, Hiroshi ^a   Horiuchi, Takahiko ^a   Nagano, Shuji ^a   Uchino, Ayumi ^a   Ota, Toshiyuki ^a   Akahoshi, Mitsuteru ^a   Akashi, Koichi ^a  

^a ASO IIZUKA HOSPITAL   (Japan)

Author keywords

BDMARDs (biologic agents); Cytokines; IL 6; Rheumatoid arthritis; TNF

Indexed keywords

ANTIRHEUMATIC AGENT; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MONOCLONAL ANTIBODY; TOCILIZUMAB; TUMOR NECROSIS FACTOR;

AGED; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; STATISTICS AND NUMERICAL DATA;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RECEPTORS, INTERLEUKIN-6; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85037988617     PISSN: None     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-017-1387-9     Document Type: Article

References (0)